Systematic Review and Meta-Analysis of Plasma and Urine Biomarkers for CKD Outcomes.

Caroline LiuNeha DebnathGohar MosoyanKinsuk Chauhan George Vasquez-RiosCeline SoudantSteve MenezChirag R Parikh Steven G Coca

Published in: Journal of the American Society of Nephrology : JASN (2022)

Studies of preclinical biomarkers for CKD outcomes have considerable heterogeneity across study cohorts and designs, limiting comparisons of prognostic performance across studies. Plasma TNFR1, FGF23, TNFR2, KIM-1, and suPAR were among the most frequently investigated in the setting of CKD outcomes.

Keyphrases

chronic kidney disease
metabolic syndrome
single cell
bone marrow
mass spectrometry